MXPA02012424A - Ensayo de combinacion de antigenos/anticuerpos para el virus de hepatitis c. - Google Patents

Ensayo de combinacion de antigenos/anticuerpos para el virus de hepatitis c.

Info

Publication number
MXPA02012424A
MXPA02012424A MXPA02012424A MXPA02012424A MXPA02012424A MX PA02012424 A MXPA02012424 A MX PA02012424A MX PA02012424 A MXPA02012424 A MX PA02012424A MX PA02012424 A MXPA02012424 A MX PA02012424A MX PA02012424 A MXPA02012424 A MX PA02012424A
Authority
MX
Mexico
Prior art keywords
antibody combination
hcv antigen
combination assay
assay
hcv
Prior art date
Application number
MXPA02012424A
Other languages
English (en)
Inventor
David Y Chien
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27395684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA02012424(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of MXPA02012424A publication Critical patent/MXPA02012424A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Abstract

La presente invencion proporciona un ensayo de combinacion de antigenos de nucleo y anticuerpos NS3/4a del VHC que puede detectar tanto antigenos como anticuerpos del VHC presentes en una muestra utilizando una matriz solida individual, asi como tambien soportes solidos para inmunoensayos para el uso en el ensayo.
MXPA02012424A 2000-06-15 2001-06-14 Ensayo de combinacion de antigenos/anticuerpos para el virus de hepatitis c. MXPA02012424A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21208200P 2000-06-15 2000-06-15
US28086701P 2001-04-02 2001-04-02
US28081101P 2001-04-02 2001-04-02
PCT/US2001/019369 WO2001096875A2 (en) 2000-06-15 2001-06-14 Hcv antigen/antibody combination assay

Publications (1)

Publication Number Publication Date
MXPA02012424A true MXPA02012424A (es) 2003-04-25

Family

ID=27395684

Family Applications (2)

Application Number Title Priority Date Filing Date
MXPA02012401A MXPA02012401A (es) 2000-06-15 2001-06-14 Inmunoensayos para anticuerpos anti-virus de hepatitis c.
MXPA02012424A MXPA02012424A (es) 2000-06-15 2001-06-14 Ensayo de combinacion de antigenos/anticuerpos para el virus de hepatitis c.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MXPA02012401A MXPA02012401A (es) 2000-06-15 2001-06-14 Inmunoensayos para anticuerpos anti-virus de hepatitis c.

Country Status (23)

Country Link
US (5) US6630298B2 (es)
EP (2) EP1354204B2 (es)
JP (3) JP4837229B2 (es)
CN (3) CN1214244C (es)
AT (2) ATE348337T1 (es)
AU (2) AU2001272945A1 (es)
BG (1) BG66205B1 (es)
BR (2) BRPI0111731C1 (es)
CA (2) CA2413003C (es)
CY (2) CY1107537T1 (es)
CZ (1) CZ304185B6 (es)
DE (2) DE60125240T3 (es)
DK (2) DK1354204T4 (es)
ES (2) ES2288969T3 (es)
HK (2) HK1061861A1 (es)
HU (1) HU228873B1 (es)
MX (2) MXPA02012401A (es)
NO (1) NO332275B1 (es)
PL (1) PL213363B1 (es)
PT (2) PT1350105E (es)
SI (1) SI1354204T2 (es)
SK (1) SK287694B6 (es)
WO (2) WO2001096870A2 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0697888B1 (en) * 1993-05-12 2003-09-17 Chiron Corporation Conserved motif of hepatitis c virus e2/ns1 region
SI1354204T2 (sl) * 2000-06-15 2010-09-30 Novartis Vaccines & Diagnostic Hcv antigen antitelo kombinacijska analiza
US7491808B2 (en) * 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
CA2419418A1 (en) * 2000-08-17 2002-02-21 Tripep Ab Vaccines containing ribavirin and methods of use thereof
DE10106295C1 (de) * 2001-02-02 2002-08-22 Gaifar German American Inst Fo Protein mit mehreren Antigen-Epitop-Sequenzen, welches immobilisiert ist
AU785380B2 (en) * 2001-03-28 2007-03-15 Ortho-Clinical Diagnostics, Inc. A hepatitis C antigen - antibody combination assay for the early detection of HCV infection
WO2003002749A2 (en) 2001-06-26 2003-01-09 Abbott Laboratories Methods for the simultaneous detection of hcv antigens and hcv antibodies
US7101683B2 (en) 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
US7049060B2 (en) * 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
US7332269B2 (en) * 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
EP1546414B1 (en) * 2002-09-09 2008-10-08 Novartis Vaccines and Diagnostics, Inc. Hcv assay
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
JP4668191B2 (ja) 2003-08-20 2011-04-13 アモールフィックス・ライフ・サイエンシィズ・リミテッド タンパク質立体配座を検出するためのエピトープ保護アッセイおよび方法
ES2377978T3 (es) * 2004-08-27 2012-04-03 Novartis Vaccines And Diagnostics, Inc. Mutantes de proteínas no estructurales de VHC y usos de los mismos
EP1845378A4 (en) * 2005-02-02 2008-09-17 Peng Cui KIT ANTIBODY DETECTION KIT AND PREPARATION METHOD THEREOF
US7527801B2 (en) 2005-11-22 2009-05-05 Novartis Vaccines And Diagnostics, Inc. Norovirus and Sapovirus antigens
US7887803B2 (en) 2005-12-02 2011-02-15 Amorfix Life Sciences Methods and compositions to treat misfolded-SOD1 mediated diseases
US7794692B2 (en) * 2005-12-02 2010-09-14 Amorfix Life Sciences Ltd. Methods and compositions for detecting amyotrophic lateral sclerosis
AU2007219615B2 (en) 2006-03-03 2013-11-28 Promis Neurosciences Inc. Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
CN1908666B (zh) * 2006-08-14 2010-05-12 武汉大学 一种检测乙肝核心抗体的双夹心法酶联免疫诊断试剂盒及应用
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
ES2497016T3 (es) * 2009-03-30 2014-09-22 bioMérieux Soporte sólido de detección del VHC
US20100297607A1 (en) * 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
BR112012025364A2 (pt) 2010-04-07 2015-09-22 Novartis Ag método para geração de partícula semelhante a vírus de parvovírus b19
WO2011158174A1 (en) * 2010-06-17 2011-12-22 Koninklijke Philips Electronics N.V. Multi epitope assay
AU2011276328C1 (en) 2010-07-06 2016-01-21 Novartis Ag Norovirus derived immunogenic compositions and methods
US20120009196A1 (en) * 2010-07-08 2012-01-12 Abbott Laboratories Monoclonal antibodies against hepatitis c virus core protein
CN103298941A (zh) * 2011-01-13 2013-09-11 奥索临床诊断有限公司 苍白密螺旋体三联抗原
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
EP3564384A1 (en) 2013-03-14 2019-11-06 Abbott Laboratories Hcv core lipid binding domain monoclonal antibodies
CN105228649B (zh) * 2013-03-14 2019-01-18 雅培制药有限公司 Hcv抗原-抗体组合测定和方法以及用在其中的组合物
US9790478B2 (en) 2013-03-14 2017-10-17 Abbott Laboratories HCV NS3 recombinant antigens and mutants thereof for improved antibody detection
CN103630690B (zh) * 2013-12-17 2014-08-20 朱之炜 丙型肝炎病毒抗原抗体联合检测试剂盒及其检测方法
DK3274478T3 (da) 2015-03-27 2020-11-23 Ortho Clinical Diagnostics K K Hcv-ns4a/modificerede ns3-polypeptider og anvendelser deraf
WO2016172121A1 (en) * 2015-04-20 2016-10-27 Qoolabs, Inc. Camelid single-domain hcv antibodies and methods of use
CN111164221B (zh) * 2017-09-27 2024-03-29 生物辐射实验室股份有限公司 数字化亲和连接试验
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒
CN115838420B (zh) * 2022-10-31 2023-05-05 北京科跃中楷生物技术有限公司 一种可溶性hcv重组蛋白的制备方法及其制备的抗体检测试剂

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074422C (zh) 1987-11-18 2001-11-07 希龙股份有限公司 制备含有hcv表位的分离多肽的方法
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
GB2212511B (en) * 1987-11-18 1992-01-22 Chiron Corp Hepatitis c virus
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
JP2730153B2 (ja) 1989-03-16 1998-03-25 日本合成ゴム株式会社 熱可塑性樹脂組成物およびその製造方法
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
MC2188A1 (fr) * 1989-05-18 1992-09-16 Chiron Corp Diagnostic du nanbv:polynucleotides permettant de depister le virus de l'hepatite c
US5712087A (en) 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
PL172133B1 (pl) * 1990-04-04 1997-08-29 Chiron Corp Sposób tworzenia kombinacji antygenów wirusowego zapalenia watroby typu C (HCV) i sposób wykrywania przeciwcial przeciw wirusowemu zapaleniu watroby typu C (HCV) PL PL PL PL PL PL
CA2049679C (en) 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
PT97247B (pt) * 1991-04-03 1997-10-31 Chiron Corp Processo de preparacao de combinacoes de antigenios do virus da hepapite c (hcv) para uso em imunoensaios para anticorpos anti-hcv
JP3516681B2 (ja) 1991-06-24 2004-04-05 カイロン コーポレイション Ｃ型肝炎ウイルス（ｈｃｖ）ポリペプチド
UA39944C2 (uk) 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
US6762024B2 (en) * 1993-04-27 2004-07-13 Innogenetics, S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5843752A (en) 1995-05-12 1998-12-01 Schering Corporation Soluble active hepatitis C virus protease
US5990276A (en) 1996-05-10 1999-11-23 Schering Corporation Synthetic inhibitors of hepatitis C virus NS3 protease
US6514731B1 (en) * 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
ATE311463T1 (de) * 1996-05-24 2005-12-15 Chiron Corp Fusionsprotein mit multiplen epitopen
US6322965B1 (en) * 1997-02-10 2001-11-27 Advanced Life Science Institute, Inc. Chimera antigen peptide
DE69837155T2 (de) * 1997-09-22 2007-06-21 Novartis Vaccines and Diagnostics, Inc., Emeryville Verfahren zum nachweiss von antikörpern in einer probe
ATE412904T1 (de) * 1998-07-30 2008-11-15 Advanced Life Science Inst Inc Verfahren zur bestimmung von hepatitis c viren
SI1354204T2 (sl) * 2000-06-15 2010-09-30 Novartis Vaccines & Diagnostic Hcv antigen antitelo kombinacijska analiza

Also Published As

Publication number Publication date
DE60129598D1 (de) 2007-09-06
US20020146685A1 (en) 2002-10-10
ES2277932T5 (es) 2010-06-28
NO20025878D0 (no) 2002-12-06
WO2001096875A9 (en) 2002-08-15
HUP0500444A3 (en) 2010-03-29
SK17772002A3 (sk) 2003-10-07
SK287694B6 (sk) 2011-06-06
WO2001096875A2 (en) 2001-12-20
US20020192639A1 (en) 2002-12-19
US6632601B2 (en) 2003-10-14
DE60125240D1 (de) 2007-01-25
BRPI0111731B8 (pt) 2016-08-23
BG107441A (bg) 2004-01-30
BRPI0111682B1 (pt) 2017-09-19
NO20025878L (no) 2003-02-12
HK1079796A1 (en) 2006-04-13
CN1489692A (zh) 2004-04-14
BR0111731A (pt) 2004-02-10
BR0111682A (pt) 2004-01-06
ES2277932T3 (es) 2007-08-01
SI1354204T1 (sl) 2007-04-30
CN1256591C (zh) 2006-05-17
AU2001272945A1 (en) 2001-12-24
DK1354204T4 (da) 2010-06-14
CA2413003A1 (en) 2001-12-20
CY1106820T1 (el) 2012-05-23
MXPA02012401A (es) 2003-04-25
CZ304185B6 (cs) 2013-12-11
US7319144B2 (en) 2008-01-15
CN100463922C (zh) 2009-02-25
ATE368221T1 (de) 2007-08-15
PT1350105E (pt) 2007-08-13
US20040063092A1 (en) 2004-04-01
SI1354204T2 (sl) 2010-09-30
CZ20024058A3 (cs) 2003-09-17
EP1354204B2 (en) 2010-04-21
EP1354204A2 (en) 2003-10-22
DE60125240T3 (de) 2010-10-28
EP1354204B1 (en) 2006-12-13
CY1107537T1 (el) 2013-03-13
US20040265801A1 (en) 2004-12-30
WO2001096875A3 (en) 2003-08-28
DE60125240T2 (de) 2007-07-12
EP1350105B1 (en) 2007-07-25
DK1350105T3 (da) 2007-11-12
JP2004510133A (ja) 2004-04-02
JP4837229B2 (ja) 2011-12-14
US20040096822A1 (en) 2004-05-20
JP2004506878A (ja) 2004-03-04
PT1354204E (pt) 2007-03-30
DK1354204T3 (da) 2007-04-10
CN1214244C (zh) 2005-08-10
ATE348337T1 (de) 2007-01-15
CN1660913A (zh) 2005-08-31
CA2412035A1 (en) 2001-12-20
JP4834279B2 (ja) 2011-12-14
WO2001096870A2 (en) 2001-12-20
HK1061861A1 (en) 2004-10-08
US6797809B2 (en) 2004-09-28
CN1466682A (zh) 2004-01-07
WO2001096870A3 (en) 2003-07-31
NO332275B1 (no) 2012-08-13
EP1350105A2 (en) 2003-10-08
DE60129598T2 (de) 2008-04-17
CA2412035C (en) 2012-04-10
US7241879B2 (en) 2007-07-10
HUP0500444A2 (hu) 2005-08-29
AU2001272948A1 (en) 2001-12-24
BG66205B1 (bg) 2012-01-31
ES2288969T3 (es) 2008-02-01
BRPI0111731C1 (pt) 2021-07-27
JP2011125350A (ja) 2011-06-30
US6630298B2 (en) 2003-10-07
BRPI0111682B8 (pt) 2021-07-27
CA2413003C (en) 2013-08-13
PL213363B1 (pl) 2013-02-28
BRPI0111731B1 (pt) 2016-07-05
HU228873B1 (hu) 2013-06-28
PL365599A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
MXPA02012424A (es) Ensayo de combinacion de antigenos/anticuerpos para el virus de hepatitis c.
HUP0303134A3 (en) Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv
NO20051715L (no) HCV assay
WO2002090961A3 (en) Systems and methods for detection of analytes in biological fluids
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
NO20004412D0 (no) HIV regulatoriske og hjelpepeptider, antigener, vaksine, blandinger, immunoassay, kit og en fremgangsmÕte for pÕvisning av antistoffer som blir infusert av HIV
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
MY137138A (en) Diagnostic reagents and preparing methods thereof
EP1829891A3 (en) Immunoassays for Anti-HCV Antibodies
AU4186299A (en) Rapid immunoassay to detect antibodies in saliva to disease-related microorganisms antigens

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status